Reference | Date | Place | Stroke (n) | ELVO (n) | Age (mean) | Sex (%) | Race (%) | Comorbidities (%) | Outcome (%) | |||||||
Male | Female | White | Black | Latino | Hypertension | Diabetes | Obesity | Rehab | Death | mRS 4–5 | ||||||
Oxley et al3 | April 2020 | USA | — | 5 | 40.4 | 80 | 20 | — | — | — | — | — | — | — | — | — |
Yaghi et al1 | July 2020 | USA | 32 | 6 | 55 | — | — | 50 | 50 | — | 100 | 33 | — | 33 | 33 | 33 |
Altschul et al44 | August 2020 | USA | — | 13 | 68 | 38 | 62 | 8 | 38 | 46 | 69 | 46 | — | 23 | 54 | 8 |
Grewal et al47 | August 2020 | USA | 13 | 3 | — | — | — | 33 | — | 66 | 66 | 100 | — | 66 | 33 | — |
Ntaios et al48 | September 2020 | World | 174 | 21 | — | — | — | — | — | — | 68 | 31 | 37 | — | 28 | 28 |
Majidi et al29 | September 2020 | USA | — | 24 | 59 | 75 | 25 | 8 | 37 | 50 | 42 | 29 | — | — | — | — |
Tiwari et al49 | September 2020 | USA | — | 8 | 55 | 100 | 0 | 13 | 50 | — | 63 | 50 | — | 25 | 63 | 13 |
de Havenon et al46 | September 2020 | USA | — | 104 | 58* | 68 | 32 | 26 | 26 | 19 | 71 | 47 | 25 | 47 | 30 | 23 |
Trifan et al50 | November 2020 | USA | 64 | 7 | — | 57 | 43 | — | — | — | — | — | — | — | 27 | — |
Bekelis et al45 | December 2020 | USA | 86 | 1 | 54 | 100 | — | — | — | — | — | — | — | — | — | — |
*Estimated from data provided.
ELVO, emergent large vessel occlusion; mRS, modified Rankin Scale.